Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose

International Journal of Cancer

Volumn 80, Issue 4, 1999, Pages 539-545

  Mauthe, Robert J ^a   Dingley, Karen H ^a   Leveson, Steven H ^b   Freeman, Stewart P H T ^a   Turesky, Robert J ^c   Garner, R Colin ^d   Turteltaub, Kenneth W ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b YORK HOSPITAL   (United Kingdom)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; CARBON 14; DNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CARCINOGENICITY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DIETARY INTAKE; DNA ADDUCT; DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL; TOXICOKINETICS;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL AVAILABILITY; COLON; DNA ADDUCTS; HUMANS; MALE; MICE; MIDDLE AGED; MUTAGENS; QUINOXALINES; RATS; RATS, INBRED F344;

EID: 0033521847     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990209)80:4<539::AID-IJC10>3.0.CO;2-C     Document Type: Article

References (22)

1. BOOBIS, A.R., GOODERHAM, N.J., RICH, K.J., ZHAO, K., EDWARDS, R.J., MURRAY, B.P., LYNCH, A.M., MURRAY, S. and DAVIES, D.S., Enzymatic studies of the activation of heterocyclic food mutagens in man. Princess Takamatsu Symp., 23, 134-144 (1995).
2. FRANTZ, C.E., BANGERTER, C., FULTZ, E., MAYER, K.M., VOGEL, J.S. and TURTELTAUB, K. W., Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis, 16, 367-373 (1995).
3. KAYE, B., GARNER, R.C., MAUTHE, R.J., FREEMAN, S.P.H.T. and TURTELTAUB, K. W., A preliminary evaluation of accelerator mass spectrometry in the biomedical field. J. pharm. biomed. Anal., 16, 541-542 (1997).
4. LANG, N.P., BUTLER, M.A., MASSENGILL, J., LAWSON, M., STOTTS, R.C., HAUER-JENSEN, M. and KADLUBAR, F.F., Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev., 3, 675-682 (1994).
5. LAYTON, D.W., BOGEN, K.T., KNIZE, M.G., HATCH, F.T., JOHNSON, V.M. and FELTON, J.S., Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis, 16, 39-52 (1995).
6. LUTZ, W.K., In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutation Res., 65, 289-356 (1979).
7. MONRO, A. and MORDENTI, J., Expression of exposure in negative carcinogenicity studies: dose/body weight, dose/body surface area, or plasma concentrations?. Toxicol. Pathol. 23, 187-198 (1995).
8. 32P-postlabeling method, in the liver of rats fed MeIQx. Carcinogenesis, 14, 2165-2170 (1993).
9. OHGAKI, H., TAKAYAMA, S. and SUGIMURA, T., Carcinogenicities of heterocyclic amines in cooked food. Mutation Res., 259, 399-410 (1991).
10. RICH, K.J., MURRAY, B.P., LEWIS, I., RENDELL, N.B., DAVIES, D.S., GOODERHAM, N.J. and BOOBIS, A.R., N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver. Carcinogenesis, 13, 2221-2226 (1992).
11. STILLWELL, W.G., TURESKY, R.J., GROSS, G.A., SKIPPER, P.L. and TANNENBAUM, S.R., Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline (MeIQx). Cancer Epidemiol. Biomarkers Prev., 3, 399-405 (1994).
12. TASK GROUP ON REFERENCE MAN, Report of international commission on radiological protection. Publication 23, pp. 135-136. Pergamon Press, Oxford (1975).
13. THIÉBAUD, H.P., KNIZE, M.G., KUZMICKY, P.A., HSIEH, D.P. and FELTON, J.S., Airborne mutagens produced by frying beef, pork and soy-based food. Food Chem. Toxicol., 33, 821-828 (1995).
14. 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxal ine (dG-C8-MeIQx) in human tissues. Carcinogenesis, 17, 1029-1034 (1996).
15. TURESKY, R.J., GARNER, R.C., WELTI, D.H., RICHOZ, J., LEVESON, S.H., DINGLEY, K.H., TURTELTAUB, K.W. and FAY, L.B., Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4.5-f ]quinoxaline in humans. Chem. Res. Toxicol., 11, 217-225 (1998).
16. TURESKY, R.J., GROSS, G.A., STILLWELL, W.G., SKIPPER, P.L. and TANNENBAUM, S.R., Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring. Environ. Hlth Perspect., 102, Suppl. 6, 47-51 (1994).
17. TURESKY, R.J., LANG, N.P., BUTLER, M.A., TEITEL, C.H. and KADLUBAR, F.F., Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845 (1991).
18. 2 atoms of guanine. Chem. Res. Toxicol., 5, 479-490 (1992).
19. TURTELTAUB, K.W., FELTON, J.S., GLEDHILL, B.L., VODGEL, J.S., SOUTHON, J.R., CAFFEE, M.W., FINKEL, R.C., NELSON, D.E., PROCTOR, I.D. and DAVIS, J.C., Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc. nat. Acad. Sci. (Wash.), 87, 5288-5292 (1990).
20. TURTELTAUB, K.W., KNIZE, M.G., HEALY, S.K., TUCKER, J.D. and FELTON, J.S., The metabolic disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the induced mouse. Food Chem. Toxicol., 27, 667-673 (1989).
21. TURTELTAUB, K.W., MAUTHE, R.J., DINGLEY, K.H., VOGEL, J.S., FRANTZ, C.E., GARNER, R.C. and SHEN, N., MeIQx-DNA-adduct formation in rodent and human tissues at low doses. Mutation Res., 376, 243-252 (1997).
22. VOGEL, J.S., TURTELTAUB, K.W., FINKEL, R. and NELSON, D.E., Accelerator mass spectrometry - isotope quantification at attomole sensitivity. Anal. Chem., 67, A353-A359 (1995).